Delivery Order SPE2DB20D1109-SPE2DB22FN99P

Award Date 4/12/22
Potential Completion Date 4/13/22
Potential Value $1.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,920.26 firm fixed-price delivery order is for the supply of 4,553,237,348 units of Oxycodone Hydrochloride 5 mg tablets. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,166.60 firm fixed-price delivery order is for the supply of 4,566,556,083 units of Oxycodone HCl (IR) 5 mg tablets in 100-count bottles, with a completion date of November 27, 2024. AmerisourceBergen is the prime contractor and no set-aside designation was used for this award. This delivery order is part of a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $1,081.49, is for the delivery of Oxycodone Hydrochloride (IR) 5 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,814,520 units of Oxycodone HCL (IR) 5 mg tablets in 100-count bottles, with a total ceiling value of $1,532.87. The contract is a firm-fixed-price delivery order, with an ultimate completion date of June 6, 2024. This contract is not designated as a set-aside....
This federal contract award, valued at $1,162.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order and has a firm fixed price pricing type, with an ultimate completion date of March 28, 2025. The contract covers the delivery of 4567720782 units of Oxycodone HCL (IR) 5 mg tablets, a critical pain management medication, to support federal healthcare programs....
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,471.18 firm-fixed-price delivery order is for the supply of 4,567,460,541 units of 5 mg oxycodone HCL immediate-release tablets. The contract has an ultimate completion date of March 5, 2025 and was awarded on March 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,537.01 firm fixed price delivery order is for 4,563,348,058 units of Oxycodone Hydrochloride 5 mg tablets. This award is part of Amerisourcebergen's existing indefinite delivery contract with DLA to provide pharmaceuticals and medical supplies in support of military treatment programs and facilities. No set-aside designation was used...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,460.22, is for the delivery of 4,567,012,938 units of 5 mg Oxycodone HCL immediate-release tablets. The contract is a Firm Fixed Price Delivery Order with a period of performance through January 23, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $1,010.00 order is for the supply of 100 units of 5 mg oxycodone HCL immediate release tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,276,278 tablets of 5 milligram oxycodone hydrochloride immediate release for a potential value of $1,309.20. The contract has a completion date of January 10, 2024. Amerisourcebergen Drug Corp is the prime contractor and Cencora, Inc. is listed as the parent company. No set-aside designation was used for this...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB22FN99P
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,240.76 Firm Fixed Price Delivery Order covers the supply of 4,556,883,698 units of Oxycodone HCL (IR) 5 mg tablets in 100-count bottles. This delivery order is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which provides a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs. These IDCs enable the efficient government procurement of essential pharmaceutical and medical supplies to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 11:30 AM